The push to attract volunteers was prompted by an increase in clinical trials being conducted at Yale. There are hundreds of clinical trials taking place here at any given time for many different types of diseases, both common and rare. Many trials do not have enough volunteers sign up to effectively test new treatments. Adding to the problem of low enrollment is the fact that there is a shortage of minority, adolescent and cancer patient volunteers.
Yale researchers and physicians point out that when people participate in clinical trials, they contribute to medical advances that benefit everyone. These advances would not be possible if it weren’t for clinical trials.
For example, Kevan Herold, MD is leading a trial to prevent Type 1 diabetes. The trial is testing whether a drug used to prevent insulin loss in diabetes can halt its development in those who are at very high risk of developing the disease.
Pramod Mistry, MD, PhD, conducts research on Gaucher disease, a rare genetic disorder that leads to enlarged liver, spleen, low blood counts, and devastating bone disease. He is working on developing a more effective, less expensive treatment and is currently conducting an observational study on patients with this disease.To find clinical studies that need volunteers, click here.